Reactive Robotics GmbH, a Munich, Germany-based medical device startup, received a second seven-digit funding round.
Backers included Dr. Doll Holding GmbH, which joined existing investors MTIP MedTech Innovation Partners AG, High-Tech Gründerfonds, Bayern Kapital and TQ-Group.
The company intends to use the funds to accelerate the international market entry.
Founded in 2015, by CEO Dr. Alexander Koenig, Reactive Robotics is developing an intelligent therapy device that replaces manual Very Early Mobilization (VEM) therapy with a robotic solution for intensive care patients as early as 24 hours after hospital admission, directly in the patient’s bed.
Since incorporation, the company has reached the following results:
– prototype development,
– establishment of a quality management system, and
– cooperation with business partners and suppliers.